ShogunPartnersNetwork
Module 6
The current live signup pages can be seen at the following URLs:
https://fractionation.org/ (redirects to a page hosted at the derekrake.com server for A/B testing purposes)
https://fractionationhypnosis.com/
The signup conversion rate varies between 44% (Google traffic funneled through a blog article) and 58% (YouTube traffic). You should be aiming for a ~50% signup rate with this template.
Let's look under the hood.
Here’s how each component of the page drives signups:
This page converts at rates between 44% (Google traffic funneled through a blog article) and 58% (YouTube traffic). You should be aiming for a ~50% signup rate with this template.
You should expect about +10% improvement for traffic from these countries–
Australia, Canada, South Africa, UK, US
Some countries like India may register high signup rates but the sales conversions are poor and refunds may be high.
For optimized performance, consider excluding traffic from–
Bangladesh, Pakistan, Nigeria, Papua New Guinea, Cambodia, Kenya, Mongolia, Myanmar, Uganda
If you’re using AWeber, contact us for the sharing code. All you need to do is to click a link and the copied landing page will appear as a template in your account.
Otherwise, you can replicate this form yourself or get a coder to help you. Here are the graphic files for you to use freely on your own page (right click and save as):
These images are already optimized for size and so you can use them as they are. If you need the high definition versions, let us know.
Fonts used are Segoe UI and Helvetica Neue.
Fast loading times increase the likelihood for signups. Below are the results of our Pingdom benchmark–
Aim to match or beat us. Loading time under 500ms is completely doable with the right optimization!
Next: The 33-day email sequence.
ShogunPartnersNetwork
© Shogun Partners Network. All rights reserved. Unauthorized distribution and/or copying of the materials on this website is strictly prohibited. Read our fascinating privacy policy and earnings disclaimer.